cGMP-mediated inhibition of TNF-α production by the atrial natriuretic peptide in murine macrophages

Journal of Immunology

Volumn 165, Issue 1, 2000, Pages 175-181

  Kiemer, Alexandra K ^a   Hartung, Thomas ^b   Vollmar, Angelika M ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

6 ANILINO 5,8 QUINOLINEQUINONE; ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; DIBUTYRYL CYCLIC GMP; GUANYLATE CYCLASE; HS 142 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; INFLAMMATION; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT;

EID: 0034234526     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.1.175     Document Type: Article

References (60)

1. Rosenzweig, A., and C. E. E. Seidman. 1991. Atrial natriuretic factor and related peptide hormones. Annu. Rev. Biochem. 60:229.
2. Levin, E. R., D. G. Gardner, and W. K. Samson. 1998. Natriuretic peptides. N. Engl. J. Med. 339:121.
3. Bovy, P. R. 1990. Structure activity in the atrial natriuretic peptide (ANP) family. Med. Res. Rev. 10:115.
4. Garbers, D. L. 1992. Guanylyl cyclase receptors and their endocrine, paracrine and autocrine ligands. Cell 71:1.
5. Maack, T. 1996. Role of atrial natriuretic factor in volume control. Kidney Int. 49:1732.
6. Sudoh, T., N. Minamino, K. Kangawa, and H. Matsuo. 1990. C-type natriureic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem. Biophys. Res. Commun. 168:863.
7. Nazario, B, R.-M. Hu, A. Pedram, B. Prins, and E. R. Levin. 1995. Atrial and brain natriuretic peptides stimulate the production and secretion of C-type natriuretic peptide from bovine aortic endothelial cells. J. Clin. Invest. 95:1151.
8. Vollmar, A. M., and R. Schulz. 1994. Gene expression and secretion of atrial natriuretic peptide in murine macrophages. J. Clin. Invest. 94:539.
9. Vollmar, A. M., and R. Schulz. 1995. Expression and differential regulation of natriuretic peptides in mouse macrophages. J. Clin. Invest. 95:2442.
10. Levin, E. R. 1993. Natriuretic peptide C-receptor: more than a clearance receptor. Am. J. Physiol. 264:E483.
11. Gutkowska, J., and M. Nemer. 1989. Structure, expression, and function of atrial natriuretic factor in extraatrial tissues. Endocr. Rev. 10:519.
12. Vollmar, A. M. 1996. Natriuretic peptides and immune function. In Natriuretic Peptides in Health and Disease. W. K. Samson and E. R. Levin, eds. Humana, Clifton, NJ, p. 275-288.
13. Vollmar, A. M., R. E. Lang, J. Hanze, and R. Schulz. 1990. The rat thymus: a site of atrial natriuretic peptide synthesis. Peptides 11:33.
14. Vollmar, A. M., K. N. Schmidt, and R. Schulz. 1996. Natriuretic peptide receptors on rat thymocytes: inhibition of proliferation by atrial natriuretic peptide. Endocrinology 137:1706.
15. Kiemer, A. K., and A. M. Vollmar. 1997. Effects of different natriuretic peptides on nitric oxide synthesis in macrophages. Endocrinology 138:4282.
16. Vollmar, A. M. 1997. Influence of atrial natriuretic peptide on thymocyte development in fetal thymic organ culture. J. Neuroimmunol. 78:90.
17. Vollmar, A. M., R. Förster, and R. Schulz. 1997. Effects of atrial natriuretic peptide on phagocytosis and respiratory burst in murine macrophages. Eur. J. Pharmacol. 319:279.
18. Vollmar, A. M., and R. Schulz. 1995. Atrial natriuretic peptide inhibits nitric oxide synthesis in mouse macrophages. Life Sci. 56:149.
19. Kiemer, A. K., and A. M. Vollmar. 1998. Autocrine regulation of the inducible nitric oxide synthase by atrial natriuretic peptide in macrophages. J. Biol. Chem. 273:13444.
20. Gerbes, A. L., A. M. Vollmar, A. K. Kiemer, and M. Bilzer. 1998. The guanylate cyclase-coupled natriuretic peptide receptor: a new target for prevention of cold ischemia-reperfusion damage of the rat liver. Hepatology 28:1309.
21. Colletti, L. M., D. G. Remick, G. D. Burtch, S. L. Kunkel, R. M. Stricter, and D. A. Campbell. 1990. Role of tumor necrosis factor-α in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J. Clin. Invest. 85:1936.
22. Rhoades, K. L., S. H. Golub, and J. S. Economou. 1992. The regulation of the human tumor necrosis factor α promoter region in macrophage, T cell, and B cell lines. J. Biol. Chem. 267:22102.
23. Karin, M., Z. Liu, and E. Zandi. 1997. AP-1 function and regulation. Curr. Opin. Cell Biol. 9:240.
24. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141.
25. Eigler, A., J. Moeller, and S. Endres, 1995. Exogenous and endogenous nitric oxide attenuates tumor necrosis factor synthesis in the murine macrophage cell line RAW 264.7. J. Immunol. 154:4048.
26. Neale, M. L., B. D. Williams, and N. Matthews. 1989. Tumour necrosis factor activity in joint fluids from rheumatoid arthritis patients. Br. J. Rheumatol. 28: 104.
27. Lopes-Virella, M. F. 1993. Interactions between bacterial lipopolysaccharides and serum lipoproteins and their possible role in coronary heart disease. Eur. Heart J. 14(Suppl K):118.
28. van der Poll, T., and S. F. Lowry. 1995. Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense? Shock 3:1.
29. Miyasaka, N., and Y. Hirata. 1997. Nitric oxide and inflammatory arthritides. Life Sci. 61:2073.
30. Titheradge, M. A. 1999. Nitric oxide in septic shock. Biochim. Biophvs. Acta 1411:437.
31. Aiura, K., M. Ueda, M. Endo, and M. Kitajima. 1995. Circulating concentrations and physiologic role of atrial natriuretic peptide during endotoxic shock in the rat. Crit. Care Med. 23:1898.
32. Szu-Hee, L., P. M. Starkey, and S. Gordon. 1985. Quantitative analysis of total macrophage content in adult mouse tissues. J. Exp. Med. 161:475.
33. Mosmann, T. 1983. Use of MTT colorimetric assay to measure cell activation. J. Immunol. Methods 65:55.
34. Vollmar, A. M., and R. Schulz. 1990. Dexamethasone action on rat thymic atrial natriuretic peptide. Endocrinology 127:3240.
35. Schreiber, E., P. Matthias, M. M. Müller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with "mini-extracts," prepared from a small number of cells. Nucleic Acids Res. 17:6419.
36. Lowry, O. H., N. J. Rosebrough, A. L. Fair, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265.
37. Hartung, T., A. Sauer, and A. Wendel. 1996. Testing of immunomodulatory properties in vitro. Dev. Biol. Stand. 86:85.
38. Martinet, N., P. Vaillant, T. Charles, J. Lambert, and Y. Martinet. 1992. Dexamethasone modulation of tumour necrosis factor-α (cachectin) release by activated normal human alveolar macrophages. Eur. Respir. J. 5:67.
39. Matsuda, Y., and Y. Morishita. 1993. HS-142-1: a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin. Cardiovasc. Drug Rev. 11:45.
40. Schmidt, M. J., B. D. Sawyer, L. L. Truex, W. S. S. Marshall, and J. H. Fleisch. 1985. Ly 83583; an agent that lowers intracellular levels of cyclic guanosine 3′5′-monophosphate. J. Pharmacol. Exp. Ther. 232:764.
41. Biesiada, E., M. Razandi, and E. R. Levin. 1996. Egr-1 activates basic fibroblast growth factor transcription: mechanistic implications for astrocyte proliferation. J. Biol. Chem. 271:18576.
42. Feldman, M., P. Taylor, E. Paleolog, F. M. Brennan, and R. N. Maini. 1998. Anti-TNFα therapy is useful in rheumatoid arthritis and Crohn's disease: analysis of the mechanism of action predicts utility in other diseases. Transplant. Proc. 30:4126.
43. Bidri, M., P. A. Becherel, L. Le Goff, L. Pieroni, J. J. Guillosson, P. Debre, and M. Arock. 1995. Involvement of cyclic nucleotides in the immunomodulatory effects of nitric oxide on murine mast cells. Biochem. Biophys. Res. Commun. 210:507.
44. Endres, S., H. J. Fulle, B. Sinna, D. Stoll, C. A. Dinarello, R. Gerzer, and P. C. Weber. 1991. Cyclic nucleotides differentially regulate the synthesis of tumour necrosis factor-α and interleukin-1β by human mononuclear cells. Immunology 72:56.
45. Nemeth, Z. H., C. Szabo, G. Hasko, A. L. Salzman, and E. S. Vizi. 1997. Effect of the phosphodiesterase III inhibitor amrinone on cytokine and nitric oxide production in immunostimulated J774.1 macrophages. Eur. J. Pharmacol. 339:215.
46. Sprenger, H., J. Beck, M. Nain, W. Wesemann, and D. Gemsa. 1991. The lack of receptors for atrial natriuretic peptides on human monocytes prevents a rise of cGMP and induction of tumor necrosis factor-α synthesis. Immunobiology 183:94.
47. Suga, S. I., H. Itoh, Y. Komatsu, H. Ishida, T. Igaki, J. Yamashita, K. Doi, T. H. Chun, T. Yoshimasa, I. Tanaka, and K. Nakao. 1998. Regulation of endothelial production of C-type natriuretic peptide by interaction between endothelial cells and macrophages. Endocrinology 139:1920.
48. Harbrecht, B. G., S. C. Wang, R. L. Simmons, and T. R. Billiar. 1995. Cyclic GMP and guanylate cyclase mediate lipopolysaccharide-induced Kupffer cell tumor necrosis factor-α synthesis. J. Leukocyte Biol. 57:297.
49. Arias-Diaz, J., E. Vara, C. Garcia, N. Villa, and J. L. Balibrea. 1995. Evidence for a cyclic guanosine monophosphate-dependent, carbon monoxide-mediated, signaling system in the regulation of TNF-α production by human pulmonary macrophages. Arch. Surg. 130:1287.
50. Renz, H., J. H. Gong, A. Schmidt, M. Nain, and D. Gemsa. 1988. Release of tumor necrosis factor-α from macrophages: enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J. Immunol. 141:2388.
51. Gong, J. H., H. Renz, H. Sprenger, M. Nain, and D. Gemsa. 1990. Enhancement of tumor necrosis factor-α gene expression by low doses of prostaglandin E2 and cyclic GMP. Immunobiology 182:44.
52. Hartung, T., W.-D. Döcke, F. Gantner, G. Krieger, A. Sauer, P. Stevens, H.-D. Volk, and A. Wendel. 1995. Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood 85:2482.
53. Pajkrt, D., A. Manten, T. van der Poll, M. M. Tiel-van Buul, J. Jansen, J. Wouter ten Cate, and S. J. van Deventer. 1997. Modulation of cytokine release and neutrophil function by granulocyte colony-stimulating factor during endotoxemia in humans. Blood 90:1415.
54. Hama, N., H. Itoh, G. Shirakami, S. Suga, Y. Komatsu, T. Yoshimasa, I. Tanaka, K. Mori, and K. Nakao. 1994. Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients. Biochem. Biophys. Res. Commun. 198:1177.
55. Charles, C. J., E. A. Espiner, A. M. Richards, M. G. Nicholls, and T. G. Yandle. 1996. Comparative bioactivity of atrial, brain, and C-type natriuretic peptides in conscious sheep. Am. J. Physiol. 270:R1324.
56. Cao, L., and D. G. Gardner. 1994. Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts. Hypertension 25:227.
57. Dos Reis, A. M., N. Fuijio, T. V. Dam, S. Mukaddam-Daher, M. Jankowski, J. Tremblay, and J. Gutkowska. 1995. Characterization and distribution of natriuretic peptide receptors in the rat uterus. Endocrinology 136:4247.
58. Ohyama, Y., K. Miyamoto, Y. Saito, N. Minamino, K. Kangawa, and H. Matsuo. 1992. Cloning and characterization of two forms of C-type natriuretic peptide receptor in the rat brain. Biochem. Biophys. Res. Commun. 183:743.
59. Isono, M., M. Haneda, S. Maeda, M. Omatsu-Kanbe, and R. Kikkawa. 1998. Atrial natriuretic peptide inhibits endothelin-1-induced activation of JNK in glomerular mesangial cells. Kidney Int. 53:1133.
60. Pilz, R. B., M. Suhasini, S. Idriss, I. L. Meinkoth, and G. R. Boss. 1995. Nitric oxide and cGMP analogs activate transcription from AP-1-responsive promoters in mammalian cells. FASEB J. 9:552.